239 related articles for article (PubMed ID: 9207397)
1. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies.
Najean Y; Rain JD; Billotey C
Br J Haematol; 1997 Jun; 97(3):547-50. PubMed ID: 9207397
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
3. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy.
Najean Y; Dufour V; Rain JD; Toubert ME
Br J Haematol; 1991 Oct; 79(2):271-6. PubMed ID: 1958485
[TBL] [Abstract][Full Text] [Related]
4. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry.
Sarpatwari A; Provan D; Erqou S; Sobnack R; David Tai FW; Newland AC
Br J Haematol; 2010 Dec; 151(5):477-87. PubMed ID: 20950403
[TBL] [Abstract][Full Text] [Related]
5. Accessory spleen in recurrent chronic immune thrombocytopenic purpura.
Facon T; Caulier MT; Fenaux P; Plantier I; Marchandise X; Ribet M; Jouet JP; Bauters F
Am J Hematol; 1992 Nov; 41(3):184-9. PubMed ID: 1415193
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy in idiopathic thrombocytopenic purpura: its correlation with the sequestration of autologous indium-111-labeled platelets.
Lamy T; Moisan A; Dauriac C; Ghandour C; Morice P; Le Prise PY
J Nucl Med; 1993 Feb; 34(2):182-6. PubMed ID: 8429334
[TBL] [Abstract][Full Text] [Related]
7. The sequestration of 111-In-labelled autologous platelets and the efficiency of splenectomy.
Najean Y; Rain JD; Dufour V
Nouv Rev Fr Hematol (1978); 1991; 33(6):449-50. PubMed ID: 1818297
[TBL] [Abstract][Full Text] [Related]
8. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
9. Autologous
Kazi S; Mckiddie F; Anderson J; Bagot C; Duncan C; Drummond M; Kerr R; Khan M; McColl M; Roddie H; Priddee N; Staff R; Thomas R; Watson HG
Br J Haematol; 2019 Mar; 184(6):1043-1045. PubMed ID: 29676450
[No Abstract] [Full Text] [Related]
10. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A
Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651
[TBL] [Abstract][Full Text] [Related]
11. Chronic idiopathic thrombocytopenic purpura (ITP): site of platelet sequestration and results of splenectomy. A study of 197 patients.
Gugliotta L; Isacchi G; Guarini A; Ciccone F; Motta MR; Lattarini C; Bachetti G; Mazzucconi MG; Baccarani M; Mandelli F; Tura S
Scand J Haematol; 1981 May; 26(5):407-12. PubMed ID: 7199755
[TBL] [Abstract][Full Text] [Related]
12. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?
Navez J; Hubert C; Gigot JF; Navez B; Lambert C; Jamar F; Danse E; Lannoy V; Jabbour N
Platelets; 2015; 26(6):573-6. PubMed ID: 25275667
[TBL] [Abstract][Full Text] [Related]
13. [Kinetic study of indium-111 labelled platelets in idiopathic thrombocytopenic purpura (author's transl)].
Reiffers J; Vuillemin L; Broustet A; Ducassou D
Nouv Presse Med; 1982 Jul; 11(31):2335-8. PubMed ID: 7202192
[TBL] [Abstract][Full Text] [Related]
14. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.
Giordano P; Cascioli S; Lassandro G; Marcellini V; Cardinale F; Valente F; Locatelli F; Carsetti R
Pediatr Res; 2016 Feb; 79(2):262-70. PubMed ID: 26492283
[TBL] [Abstract][Full Text] [Related]
15. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
Thromb Haemost; 1992 May; 67(5):563-6. PubMed ID: 1519215
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
17. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H
J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
[TBL] [Abstract][Full Text] [Related]
18. Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets.
Stratton JR; Ballem PJ; Gernsheimer T; Cerqueira M; Slichter SJ
J Nucl Med; 1989 May; 30(5):629-37. PubMed ID: 2497234
[TBL] [Abstract][Full Text] [Related]
19. [Value of preoperative thrombocyte marking in patients with idiopathic thrombocytopenic purpura].
Gietz M; Mempel W; Clemm C; Hiller E; Heim M; Wilmanns W
Klin Wochenschr; 1988 Jul; 66(14):633-8. PubMed ID: 3210658
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
